Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference

Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference
复制标题

DOI:
10.1038/cgt.2010.35
复制
发表时间:
2010-11-01
影响因子:
6.4
通讯作者:
Nemunaitis, J.
Nemunaitis, J.
中科院分区:
医学3区
文献类型:
--
作者:
Rao, D. D.;Maples, P. B.;Nemunaitis, J.

文献摘要

被引文献

相似文献

RNA干扰(RNA interference,RNAi)是一种通过转录、转录后和翻译机制抑制基因表达的自然细胞调控过程。模拟这一过程的合成方法(小干扰RNA(siRNA),短发夹RNA(shRNA))已被证明在这方面同样有效。我们开发了一种新的“双功能”RNAi策略,进一步优化了靶基因敲除结果。针对Stathmin 1产生双功能构建体(bi-sh-STMN 1),Stathmin 1是在人类癌症中过表达的关键微管蛋白调节剂。假设双功能构建体同时抑制靶mRNA的翻译(不依赖于切割,mRNA封存和降解)并通过切割依赖性活动降解(通过RNase H样切割)转录后mRNA。Bi-sh-STMN 1在与靶向相同序列的常规shRNA和siRNA的平行比较中显示出增强的效力和耐久性。通过快速扩增互补DNA末端(RACE)分析显示,bi-sh-STMN 1增强的STMN 1蛋白敲除伴随着mRNA水平上的靶位点切割。Bi-sh-STMN 1在mRNA水平上也表现出与其多效应子沉默机制一致的敲低动力学。双功能shRNA是一种高效且有利的方法,其在显著低于常规shRNA或siRNA的浓度下介导RNAi。这些结果支持进一步的评价。Cancer Gene Therapy(2010)17,780-791; doi:10.1038/cgt.2010.35; 2010年7月2日在线发表
RNA interference (RNAi) is a natural cellular regulatory process that inhibits gene expression by transcriptional, post-transcriptional and translational mechanisms. Synthetic approaches that emulate this process (small interfering RNA (siRNA), short hairpin RNA (shRNA)) have been shown to be similarly effective in this regard. We developed a novel 'bifunctional' RNAi strategy, which further optimizes target gene knockdown outcome. A bifunctional construct (bi-sh-STMN1) was generated against Stathmin1, a critical tubulin modulator that is overexpressed in human cancers. The bifunctional construct is postulated to concurrently repress the translation of the target mRNA (cleavage-independent, mRNA sequestration and degradation) and degrade (through RNase H-like cleavage) post-transcriptional mRNA through cleavage-dependent activities. Bi-sh-STMN1 showed enhanced potency and durability in parallel comparisons with conventional shRNA and siRNAs targeting the same sequence. Enhanced STMN1 protein knockdown by bi-sh-STMN1 was accompanied by target site cleavage at the mRNA level showed by the rapid amplification of complementary DNA ends (RACE) assay. Bi-sh-STMN1 also showed knockdown kinetics at the mRNA level consistent with its multieffector silencing mechanisms. The bifunctional shRNA is a highly effective and advantageous approach mediating RNAi at concentrations significantly lower than conventional shRNA or siRNA. These results support further evaluations. Cancer Gene Therapy (2010) 17, 780-791; doi:10.1038/cgt.2010.35; published online 2 July 2010